Young Adult Infusion Space Experience Satisfaction Survey

October 22, 2025 updated by: UNC Lineberger Comprehensive Cancer Center

Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital

The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

A subject with a cancer diagnosis and receiving infusion in the study site

Description

Inclusion Criteria:

  1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
  2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
  3. Age 18-39 years old at enrollment.
  4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
  5. English speaking.

Exclusion Criteria:

  1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
  2. Current incarceration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Outpatient treatment center
Subjects received an infusion in an outpatient infusion center.
Other: Baseline Survey
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.
Other: Semi-structured interviews
Semi-structured interviews will be conducted in the same infusion spaces.
Other: Follow-up Survey
A survey that measures participant satisfaction will be offered to participants during following infusion.
Inpatient Infusion Center
Subjects received an infusion in an inpatient infusion center.
Other: Baseline Survey
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.
Other: Semi-structured interviews
Semi-structured interviews will be conducted in the same infusion spaces.
Other: Follow-up Survey
A survey that measures participant satisfaction will be offered to participants during following infusion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General satisfaction
Time Frame: Baseline (up to 1 month)

General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Baseline (up to 1 month)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with the built environment
Time Frame: Baseline (up to 1 month)

Subject satisfaction with the built environment will be measured with a survey item specific to the built environment administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 2. Scores will be summarized using frequency tables and percentages.
Baseline (up to 1 month)
Satisfaction with staff interaction
Time Frame: Baseline (up to 1 month)

Subject satisfaction with staff interaction will be measured with a survey item specific to staff interactions administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Baseline (up to 1 month)
Satisfaction with mental health
Time Frame: Baseline (up to 1 month)

Subject satisfaction with mental health will be measured with survey items regarding emotional support and comfort administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.

Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Baseline (up to 1 month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

UNC Lineberger Comprehensive Cancer Center

Investigators

  • Principal Investigator: Jacob Stein, UNC Lineberger Comprehensive Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 20, 2023

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

January 31, 2023

First Submitted That Met QC Criteria

January 31, 2023

First Posted (Actual)

February 9, 2023

Study Record Updates

Last Update Posted (Estimated)

October 24, 2025

Last Update Submitted That Met QC Criteria

October 22, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LCCC2228

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Baseline Survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe